Is a complete GLMD research report available?

No complete published report is available for Galmed Pharmaceuticals Ltd. (GLMD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · USD

$0.60

+0.04 (+7.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GLMD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4M
Net income (ttm)	-11.1M
EPS (ttm)	-$2.02
Shares out	6.6M
Volume	107,956
Beta	0.74

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.1M
EPS (ttm): -$2.02
Market cap: 4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GLMD indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001595353
Company name	Galmed Pharmaceuticals Ltd.
Country	Israel
Country code	US
Cusip	M4R16S102
Employees	6
Employees Change	-2%
Employees Change Percent	-25
Enterprise value	$-11.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-03-13
Isin	IL0011313900
Last refreshed	2026-07-31
Market cap	$4M
Market cap category	Nano-Cap
Price	$0.6
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	GLMD
Website	https://galmedpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-287.8%
FCF yield	-198.96%
P/B ratio	0.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-11.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-33.45
Roa5y	-33.38
ROCE	-66.6
ROE	-72.12
Roe5y	-66.59
ROIC	-37.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-51.12%
Cagr1y	-66.56%
Cagr3y	-65.25%
Cagr5y	-73.43%
EPS Growth Quarters	19
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$16M
Cash	$15.5M
Current Assets	$16M
Current Liabilities	$2.1M
Debt	$0
Equity	$13.9M
Interest Coverage	-117.6
Liabilities	$2.1M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$15.5M
Net Cash By Market Cap	$400
Net Cash Growth	-1.77%
Net Debt Equity	$-1.11
Tangible Book Value	$13.9M
Tangible Book Value Per Share	$2.11
WACC	8.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.71
Net Working Capital	$-1.5M
Quick ratio	7.65
Working Capital	$13.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-350.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.92%
1Y total return	-66.54%
200-day SMA	0.77
3Y total return	-95.81%
50-day SMA	0.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.87%
All Time High	4,870.8
All Time High Change	-99.99%
All Time High Date	2018-06-12
All Time Low	0.41
All Time Low Change	45.71%
All Time Low Date	2026-03-27
ATR	0.06
Beta	0.74
Beta1y	3.31
Beta2y	2.09
Ch YTD	-20.19
High	0.6
High52	1.8
High52 Date	2025-07-30
High52ch	-66.72%
Low	0.53
Low52	0.41
Low52 Date	2026-03-27
Low52ch	45.71%
Ma50ch	2.52%
Premarket Change Percent	-4.06
Premarket Price	$0.54
Premarket Volume	9,504
Price vs 200-day SMA	-22.02%
RSI	56.91
RSI Monthly	31.27
RSI Weekly	43.78
Sharpe ratio	-0.77x
Sortino ratio	-1.02
Total Return	-350.53%
Tr YTD	-20.19
Tr1m	4.92%
Tr1w	8.32%
Tr3m	6.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.38
Operating Income	$-9.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,386,364%
Float Percent	96.77%
Shares Insiders	3.07%
Shares Institutions	4.87%
Shares Out	6,599,654
Shares Qo Q	9.58%
Shares Yo Y	350.53%
Short Ratio	0.25
Short Shares	0.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.3M
Adjusted OCF	-8,285,000
Average Volume	959,126.85x
Bv Per Share	2.11
Ch10y	-99.92
Ch1m	4.92
Ch1w	8.32
Ch1y	-66.54
Ch3m	6.95
Ch3y	-95.81
Ch5y	-99.87
Ch6m	-20.13
Change	7.02%
Change From Open	10.74
Close	0.56
Days Gap	-3.36
Dollar Volume	64,665.6
Earnings Date	2026-07-08
Earnings Time	amc
EBIT	$-9.3M
EBITDA	$-9.3M
EPS	$-2.02
F Score	1
FCF	$-7.7M
FCF EV Yield	66.3x
FCF Per Share	$-1.16
Financing CF	7,512,000
Fiscal Year End	December
Founded	2,000
Investing CF	-2,992,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-08
Last Report Date	2026-03-31
Last Split Date	2024-08-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	0.64
Ma150ch	-6.6%
Ma20	0.54
Ma20ch	10.13%
Net CF	-3,164,000
Next Earnings Date	2026-08-27
Open	0.54
Optionable	No
Position In Range	100
Post Close	0.6
Postmarket Change Percent	-4.61
Postmarket Price	$0.57
Pre Close	0.56
Price Date	2026-07-30
Ptbv Ratio	0.28
Relative Volume	0.11x
Share Based Comp	601,000
Tr6m	-20.13%
Volume	107,956

Galmed Pharmaceuticals Ltd. (GLMD)

Coverage state: Market snapshot only — no published research

Generate the first GLMD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · GLMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GLMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GLMD

Frequently asked questions